Selectis Health, INC 10-Q quarterly reports

Selectis Health, Inc. reported a significant increase in net income for the six months ended June 30, 2026, primarily driven by substantial gains from the sale of four Georgia facilities, alongside new management fee revenue.

Selectis Health reports a net income of $6.5 million for Q1 2026, driven primarily by asset sales, despite ongoing going concern uncertainties.

Selectis Health, Inc. reported a significant reduction in net loss for the nine months ended September 30, 2025, and a swing to net income for the third quarter, driven by increased healthcare revenue and employee retention credits, despite ongoing liquidity concerns and internal control weaknesses.

Selectis Health, Inc. reported a widened net loss and significant liquidity challenges for Q2 2025, raising substantial doubt about its ability to continue as a going concern.

Selectis Health saw a revenue increase in Q1 2025, but continues to face net losses and substantial doubt about its ability to continue as a going concern.

Selectis Health's Q3 2024 results show a net loss and negative operating cash flow, raising concerns about the company's ability to continue as a going concern, despite increased healthcare revenue.

Selectis Health saw an increase in healthcare revenue for Q2 2024, but continues to face challenges related to internal controls and a going concern warning.

Selectis Health's Q1 2024 results show stable revenue but a net loss, with management expressing concerns about the company's ability to continue as a going concern.